Hacker News new | ask | show | jobs
by discretion22 9 days ago
Great news! If you are a mouse.

For humans, not yet progressed to trials though safety has been evaluated for other diseases, so possible for trials to happen quickly?

" the compound has strong potential to quickly transition into human clinics because it has already undergone safety evaluations for other diseases."

4 comments

A genetically modified mouse with human amyloid-beta peptides. https://www.jax.org/strain/004462#
The Hitchhiker's Guide was right. We spend all our time inventing new cures for the mice!
It goes even further than that. since we don’t know what causes Alzheimer’s, what they’re doing is trying to cure their own laboratory-induced symptoms in mice. It’s like trying to fix a car’s ABS system by simulating tire slippage.

This is so obvious that the only thing I can think is that they simply don't care. They just want to find something that masks the symptoms (perhaps to keep patients dependent on the drug for life if they succeed).

What causes Alzheimer gentlemen? very few people is really trying to solve this answer.

Is it even known what causes the moments of lucidity in patients? Molecules should be mapped to identify the patterns (and therefore track possible sources).

mice are having a great year
I mean why not allow right to try for people who are already so far gone. It can potentially help them and all of us.
they can try it

simply this stuff was not even at that stage. it's a lab report. there's no company making it. though there's a version of this copper complex that targets ALS, and that is already available